Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas

Abstract

Adenocarcinoma is the most common type of lung cancer. Epithelial-mesenchymal transition (EMT) is required for tumor invasion/metastasis and the components that control this process are potential therapeutic targets. This study we examined the role of Gli in lung adenocarcinoma and whether its activation regulates metastasis through EMT in lung adenocarcinoma. We found that tumors with high Gli expression had significantly lower E-Cadherin expression in two independent cohorts of patients with lung adenocarcinoma that we studied. In vitro up-regulation of SHh resulted in increased cell migration while small molecule inhibitors of Smo or Gli significantly reduced cell mobility both in a wound healing assay and in a 3D cell invasion assay. Inhibition of Gli in vivo decreased tumor growth and induced an increase in E-Cadherin expression. Our results indicate that Gli may be critical for lung adenocarcinoma metastasis and that a novel Gli inhibitor shows promise as a therapeutic agent by preventing cell migration and invasion in vitro and significantly reducing tumor growth and increasing E-Cadherin expression in vivo.

DOI: 10.18632/oncotarget.11246

6 Figures and Tables

Cite this paper

@inproceedings{Li2016GliPE, title={Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas}, author={Hui Li and Dong-sheng Yue and Joy Q. Jin and Gavitt Alida Woodard and Bhairavi Tolani and Thomas M. Luh and Etienne Giroux-Leprieur and Min-li Mo and Zhao Chen and Juanjuan Che and Zhenfa Zhang and Yong Zhou and Lei Wang and Xishan Hao and David Mark Jablons and Changli Wang and Biao He}, booktitle={Oncotarget}, year={2016} }